Trial Profile
A study comparing effectiveness of Teriflunomide and Dimethyl Fumarate in patients with relapsing multiple sclerosis
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 09 May 2018
Price :
$35
*
At a glance
- Drugs Teriflunomide (Primary) ; Dimethyl fumarate
- Indications Multiple sclerosis
- Focus Therapeutic Use
- Acronyms Teri-RADAR
- 09 May 2018 New trial record
- 27 Apr 2018 Results presented at the 70th Annual Meeting of the American Academy of Neurology